| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/16/2004 | US6706741 Acetylcholinesterase inhibitors containing 1-benzyl-pyridinium salts |
| 03/16/2004 | US6706740 Controlling, prevention fungi infections |
| 03/16/2004 | US6706739 Treating enterovirus infection |
| 03/16/2004 | US6706738 Substituted bicyclic heteroaryl compounds and their use as integrin antagonists |
| 03/16/2004 | US6706737 Inhibiting gastric acid secretion are known in the art and include a class of benzimidazole- substituted compounds, one of which is omeprazole |
| 03/16/2004 | US6706732 Nasal preparation of guanidinoimino quinoline derivatives |
| 03/16/2004 | US6706731 With isoquinoline derivatives as antitumor agents |
| 03/16/2004 | US6706728 Topical cervix immune response modifiers of imidazoquinoline amines, imidazopyridine amines, imidazonaphthyridine amines, oxazoloquinoline amines, and thiazoloquinoline amines |
| 03/16/2004 | US6706727 ethyl-4-chloro- or 4-hydroxy- Ascomycin derivatives; pimecrolimus homologues; cultivating Streptomyces hygroscopius to produce the 4-hydroxy derivative; replacement of the hydroxy with chloro under epimerization; antiinflammatory; immunosupression |
| 03/16/2004 | US6706725 Vitamin D analogues |
| 03/16/2004 | US6706724 Antitumor agents; antiinflammatory agents; analgesics; antipyretic agent |
| 03/16/2004 | US6706723 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 03/16/2004 | US6706722 Heteroaryl derivatives and their use as medicaments |
| 03/16/2004 | US6706720 Heterocyclic dihydropyrimidine compounds |
| 03/16/2004 | US6706719 Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity |
| 03/16/2004 | US6706717 Thiazolyl inhibitors of Tec family tyrosine kinases |
| 03/16/2004 | US6706716 Compounds specific for the human α1d adrenergic receptor and uses thereof |
| 03/16/2004 | US6706715 Reversible inhibitors of the blood clotting enzyme factor viia |
| 03/16/2004 | US6706714 2,3,4,4a-tetrahydro-1H-pyrazino[1,2-a]quinoxalin-5(6H)one derivatives |
| 03/16/2004 | US6706712 Cyclic derivatives as modulators of chemokine receptor activity |
| 03/16/2004 | US6706711 Substituted diaminopyrazoles; treating diseases, such as cancer, inflammatory disorders, restenosis, and cardiovascular disease. coatings for implantable medical devices, such as prostheses, artificial valves, etc. |
| 03/16/2004 | US6706710 Form of (R)-N-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]-4-morpholinobenzamide |
| 03/16/2004 | US6706709 Treating, for example, proliferative disorders including cancer |
| 03/16/2004 | US6706708 Cytotoxic agents comprising taxanes and their therapeutic use |
| 03/16/2004 | US6706707 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles |
| 03/16/2004 | US6706706 Non-nucleoside reverse transcriptase inhibitors |
| 03/16/2004 | US6706704 Method of inducing opioid analgesia and anesthesia without respiratory suppression |
| 03/16/2004 | US6706702 For therapy of neurological and psychological disorders |
| 03/16/2004 | US6706701 6, 7-oxygenated steroids and uses related thereto |
| 03/16/2004 | US6706700 Novel steroids containing a 14 beta ,15 beta - cyclopropane ring and a 17 alpha hydroxymethyl group; male contraceptives |
| 03/16/2004 | US6706698 Anticholesterol agents |
| 03/16/2004 | US6706696 Cosmetic and/or pharmaceutical preparations |
| 03/16/2004 | US6706695 Antilipemic formulation |
| 03/16/2004 | US6706692 Staphylococci, streptococci, pneumococci |
| 03/16/2004 | US6706691 Bioavailability of compositions metabolized by the gut p450 isozymes |
| 03/16/2004 | US6706689 Administering glucagon like peptide-1 (glp-1), where the patient is not suffering from a q-wave myocardial infarction |
| 03/16/2004 | US6706687 Platelet-derived growth factor D |
| 03/16/2004 | US6706686 Inhibition of histone deacetylase as a treatment for cardiac hypertrophy |
| 03/16/2004 | US6706508 Isolated polypeptide comprising specified amino acid sequence, which exhibits ornithine carbamoyltransferase activity |
| 03/16/2004 | US6706290 Calcium chelation demineralization then disinfecting; preventing kidney, salivary gland and dental pulp stones and atherosclerosis |
| 03/16/2004 | US6706287 Microencapsulated or enteric coated composition comprising a probiotic, a prebiotic, and an ammoniaphilic urea degrading microorganism with high alkaline ph stability and high urease activity |
| 03/16/2004 | US6706285 Enteric coated formulation of a benzimidazole derivative and method for preparation thereof |
| 03/16/2004 | US6706282 Sustained release osmotic dosage form without delayed release coating adapted for once a day administration as suspension or slurry; such as nefazodone |
| 03/16/2004 | US6706281 Melt-extrusion multiparticulates |
| 03/16/2004 | US6706276 Compositions and methods for trapping and inactivating pathogenic microbes and spermatozoa |
| 03/16/2004 | US6706274 Differential delivery of nitric oxide |
| 03/16/2004 | US6706267 Glucosamine and egg for reducing inflammation |
| 03/16/2004 | US6706266 Oncostatin M antagonists |
| 03/16/2004 | US6706255 Liquid pharmaceutical compositions comprising thyroid hormones |
| 03/16/2004 | US6706021 Anticoagulant for catheters, dialysis machines, syringes, tubes, blood lines and stents; trypsin-like serine proteases such as thrombin; 3-benzylsulfonylamino-6-methyl-1-((2-guanidinooxyethyl) aminocarbonylmethyl)-2-pyridinone |
| 03/16/2004 | CA2294399C Farnesyl transferase inhibitors in combination with hmg coa reductase inhibitors for the treatment of cancer |
| 03/16/2004 | CA2288966C Preventives and remedies for ulcerous colitis and/or crohn's disease |
| 03/16/2004 | CA2197188C Denture adhesive |
| 03/16/2004 | CA2190847C Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases |
| 03/16/2004 | CA2105165C Dosage form for a delayed drug-delivery |
| 03/16/2004 | CA2096460C Dual action inhibitors |
| 03/16/2004 | CA2079143C Novel 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace |
| 03/11/2004 | WO2005027710A2 Methods for identifying subjects at risk of melanoma and treatments thereof |
| 03/11/2004 | WO2004021010A2 Method of diagnosing colon and gastric cancers |
| 03/11/2004 | WO2004020979A2 Methods of assaying for cell cycle modulators using components of the ubiquitin ligation cascade |
| 03/11/2004 | WO2004020631A2 Genetic suppression and replacement |
| 03/11/2004 | WO2004020468A2 Interferon beta-like molecules for treatment of cancer |
| 03/11/2004 | WO2004020436A1 Amorphous hydrates of esomeprazole magnesium and process for the preparation thereof |
| 03/11/2004 | WO2004020435A1 Piperidinyl compounds that selectively bind integrins |
| 03/11/2004 | WO2004020434A1 Azaarene derivatives |
| 03/11/2004 | WO2004020432A1 Arylamides |
| 03/11/2004 | WO2004020430A2 Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics |
| 03/11/2004 | WO2004020427A1 The process for preparation of total coumarins from cortex fraxini and their use in medicine |
| 03/11/2004 | WO2004020426A1 Process for the production of an immunosuppressant |
| 03/11/2004 | WO2004020415A1 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12. |
| 03/11/2004 | WO2004020414A1 Oxytocin inhibitors |
| 03/11/2004 | WO2004020411A1 Naphthamide derivatives and their use |
| 03/11/2004 | WO2004020409A1 Indoles having anti-diabetic activity |
| 03/11/2004 | WO2004020408A1 Indoles having anti-diabetic activity |
| 03/11/2004 | WO2004020407A1 Benzenesulfonate of 4-fluoro-2-cyanopyrrolidine derivative |
| 03/11/2004 | WO2004020403A2 A composition and method to augment and sustain neurotransmitter production |
| 03/11/2004 | WO2004020396A1 Crystalline form of nateglinide and process for preparation thereof |
| 03/11/2004 | WO2004020385A1 Process for preparing nitrooxyalkyl substituted esters of carboxylic acids, intermediates useful in said process and preparation thereof |
| 03/11/2004 | WO2004020384A1 Process for preparing nitrooxyderivatives of naproxen |
| 03/11/2004 | WO2004020382A1 Method and device for producing formic acid formates and use of said formates |
| 03/11/2004 | WO2004020289A1 Process for producing metered dose inhaler formulations |
| 03/11/2004 | WO2004020189A1 Embossable and writable multilaminate backing construction |
| 03/11/2004 | WO2004020079A1 Method for preparing colloidal solution of bismuth sodiun tartrate |
| 03/11/2004 | WO2004020014A2 Method of controlling pharmacokinetics of immunomodulatory compounds |
| 03/11/2004 | WO2004020011A1 Embolization |
| 03/11/2004 | WO2004019999A2 Agent delivery particle |
| 03/11/2004 | WO2004019994A1 Ark5 |
| 03/11/2004 | WO2004019993A1 Self-immolative dendrimers releasing many active moieties upon a single activating event |
| 03/11/2004 | WO2004019989A1 Inclusion compound of nateglinide |
| 03/11/2004 | WO2004019988A1 Adhesive patch |
| 03/11/2004 | WO2004019987A1 Adhesive patch |
| 03/11/2004 | WO2004019986A1 Methods of treating acute respiratory distress syndrome |
| 03/11/2004 | WO2004019985A1 Pharmaceutical products and compositions comprising specific anticholinergic agents, beta-2 agonists and corticosteroids |
| 03/11/2004 | WO2004019984A1 Novel combination of glucocorticoids and pde-4-inhibitors for treating respiratory diseases, allergic diseases, asthma and copd |
| 03/11/2004 | WO2004019982A1 Remedy |
| 03/11/2004 | WO2004019981A1 Method of diffrentiation and maturation of non-nerve cells into nerve cells, agent therefor and method of searching for the agent |
| 03/11/2004 | WO2004019960A2 Herbal extract comprising a mixture of saponins obtained from sapindus trifoliatus for anticonvulsant activity |
| 03/11/2004 | WO2004019959A2 Dna repair enzymes |
| 03/11/2004 | WO2004019958A1 Pyrazole derivatives, medicinal composition containing the same, and medicinal use thereof |
| 03/11/2004 | WO2004019957A1 Medicinal composition for periodontal pocket administration containing bisphosphonic acid derivative or its salt as the active ingredient |